Reproductive Potential After Adjuvant Chemotherapy for Breast Cancer
The 10-year update of the world-wide overview of breast cancer treatment (Early Breast Cancer Trialists’ Collaborative Group 1992) has confirmed that adjuvant systemic therapy can alter the course of breast cancer. In women younger than 50 years of age (i.e. in premenopausal women), highly significant reductions in the annual rates of both recurrence (37%) and death (27%) are produced by adjuvant combination chemotherapy when compared with local-regional treatment alone.
KeywordsEstrogen Leukemia Methotrexate Cyclophosphamide Anthracyclines
Unable to display preview. Download preview PDF.
- Early Breast Cancer Trialists' Collaborative Group (1992) Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31000 recurrences and 24 000 deaths among 75 000 women. Lancet 339:1–15, 71–85Google Scholar
- Mulvihill JJ, McKeen EA, Rosner F, Zarrabi MH (1987) Pregnancy outcome in cancer patients. Experience in a large cooperative group. Cancer 60: 1143–1150Google Scholar